Martin Duplantier, DDS
Oral and Maxillofacial Surgery · Houma, LANPI 1821527888
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Synthes GmbH at 40.0% of the total. Reporting peaked in 2022 at $1,649 and has fallen 88.6% since, to $188 in 2025.
Across 28 payments — averaging $88.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$994
- Zimvie Inc.$574
- Johnson & Johnson$474
- Kls-martin L.p.$159
- Geistlich Pharma, North America, Inc.$121
- Straumann USA LLC$121
- plus $41 from 2 others
What the payments were for
- Travel & lodging$99440%
- Food & beverage$1,39056%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 1 | $994 |
| Zimvie Inc. | 12 | $574 |
| Johnson & Johnson | 8 | $474 |
| Kls-martin L.p. | 2 | $159 |
| Geistlich Pharma, North America, Inc. | 1 | $121 |
| Straumann USA LLC | 2 | $121 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Clovis Oncology, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MATRIXMANDIBLE$228
- TSX Implants$124
- BIOMATERIALS$121
- TRUMATCH$108
- Diem2-RevitaliZe$100
How this compares
$2,483 in reported general payments places this provider in the 65th percentile of 103 oral and maxillofacial surgery providers in Louisiana.
See all oral and maxillofacial surgery providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 81 | $350 |
| Amoxicillin | 123 | $243 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $220 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 45 | $189 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $158 |
| Clindamycin Hcl | 28 | $90 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Houma
- David BaughmanHouma$4K
- Christopher SaalHouma$1K
- Michelle ZoccolilloNew Orleans$56K
- Waleed ZaidBaton Rouge$47K
- Michael BlockMetairie$42K
- Demarcus SmithMetairie$20K
- Jennifer WoernerShreveport$19K
- David BulotBelle Chasse$18K
- Dongsoo KimShreveport$17K
- Rathana LimNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.